WilsonKWRobinsonDCHackingPM. Portal hypertension in childhood. Br J Surg. 1969;56:13-22.
4.
Revel-VilkSChanABaumanMMassicotteP. Prothrombotic conditions in an unselected cohort of children with venous thromboembolic disease. J Thromb Haemost.2003;1:915-921.
5.
SakhaSHRafeeyMTarzamaniMK. Portal venous thrombosis after umbilical vein catheterization. Indian J Gastroenterol. 2007;26:283-284.
6.
AlvarezFBernardOBrunelleFHadchouelPOdievreMAlagilleD. Portal obstruction in children. I Clinical investigation and hemorrhage risk. J Pediatr. 1983;103:696-702.
7.
LykavierisPGauthierFHadchouelPDucheMBernardO. Risk of gastrointestinal bleeding during adolescence and early adulthood in children with portal vein obstruction. J Pediatr. 2000;136:805-808.
JensenMKCampbellKMAlonsoMHNathanJDRyckmanFCTiaoGM. Management and long-term consequences of portal vein thrombosis after liver transplantation in children. Liver Transpl. 2013;19:315-321.
10.
LicinioRPrincipiMLosurdoGCastellanetaNMIerardiEDi LeoA. Low molecular weight heparin in portal vein thrombosis of cirrhotic patients: only therapeutic purposes?ScientificWorldJournal. 2014;2014:895839. doi:10.1155/2014/895839.
11.
SchmidtBOfosuFAMitchellLBrookerLAAndrewM. Anticoagulant effects of heparin in neonatal plasma. Pediatr Res. 1989;25:405-408.
12.
GuyattGHAklEACrowtherMGuttermanDDSchuünemannHJ; American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel. Executive summary: Antithrombotic Therapy and Prevention of Thrombosis., 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 suppl):7S-47S.
13.
MichelsonADBovillEMonaglePAndrewM. Antithrombotic therapy in children. Chest. 1998;114(5 suppl):748S-769S.
14.
MalowanyJIMonaglePKnoppertDCet al; Canadian Paediatric Thombosis and Hemstasis Network. Enoxaparin for neonatal thrombosis: a call for a higher dose for neonates. Thromb Res. 2008;122:826-830.
15.
WarkentinTELevineMNHirshJet al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med. 1995;332:1330-1335.
16.
RochaEMartinez-GonzalezMAMontesRPanizoC. Do the low molecular weight heparins improve efficacy and safety of the treatment of deep venous thrombosis? A meta-analysis. Haematologica. 2000;85:935-942.
17.
DixDAndrewMMarzinottoVet al. The use of low molecular weight heparin in pediatric patients: a prospective cohort study. J Pediatr. 2000;136:439-445.
